Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC- producing bacteria Ryan G. D'Angelo, Jennifer K. Johnson, Jacqueline T. Bork & Emily L. Heil Expert Opinion on Pharma- cotherapy Vol. 17 , Iss. 7,2016D'Angelo RG, Johnson JK, Bork JT, Heil EL. Treatment options...
AmpC-producing strainwas rather hish.Most ofthe AmpC-producing strains WCl'℃multidrugresistance, and imipenem isstillthe proper antibioticfortreatmentoftheinfections caused byAmpC-producingbacteria.AmpCenzyme wasoneofthecause ofEnte*obactercloacae’resistance,Themutantof ampC structure gene may beassoci...
Objective To investigate the risk factors,producing AmpC and drug resistance status of hospital acquired infections in critical patients caused by Ochrobactrum anthropi,so as to provide scientific basis for effective prevention and treatment of the bacterial infection. Methods Retrospective study was perfor...
Objective To analyze occurrence of Gram-negative bacteria producing extended-spectrum 尾-lactamase (ESBL) in patients with lower respiratory tract infectio... J Long - 《Journal of First Military Medical University》 被引量: 23发表: 2004年 Detection of AmpC β-lactamase and drug resistance of En...
AmpCenzymebacteriaresistancetoceftriaxone,aztreonam,cefotaximeand cefotaximehavesignicantlylowerthanthatofenzymeproducingbacteria,the differencewasstatisticallysignicant(P<0.05).ConclusionESBLsandAmpC enzymeistheimportantcauseofbacteriaresistance,canbeinaccordancewith theactualdrugsusceptibilityresultstakereasonabletreatment....
Bacteria harboring the plasmid-mediated AmpC enzymes are increasingly prevalent among adult patients, but have not previously been reported in neonates. Early-onset neonatal meningitis caused by an AmpC beta-lactamase-producing Escherichia coli is described ...
A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria. AND METHOD: The authors performed a prospective study in female patients hospitalized with acute pyelonephritis caused by ESBL-producing or ESBL-nonproducing ... C Suankratay...
The predominant mechanism for resistance to beta-lactam antimicrobial agents in gram-negative bacteria is the synthesis of beta-lactamases, which are capable of hydrolyzing beta-lactam ring. AmpC beta-lactamases which are termed class C/group 1, by mutation, are one of the most important beta-la...
clinicaldiagnosisandtreatment.Methods PotentialAmpC—producingstrainsweredetectedbythecefoxitindiskdiffusionmethodasde— scribedbyCLSI2010.Three—dimensionaltestwasadoptedforconfirmingAmpC—producingstrains.TheMICsofSerratiamarcescenswere determinedbybrothmicrodilutionmethod.Theresultswerejudgedaccordingtothecriteriarecommended...
Infections caused by bacterial isolates harboring these enzymes are difficult to treat with carbapenems being the sole effective treatment option for such infections. The objective of this study was to determine the frequency of ESBLs and AmpC-producing Gram-negative bacilli isolated from clinical ...